proteomics.cancer.gov
SBIR - Office of Cancer Clinical Proteomics Research - National Cancer Institute
http://proteomics.cancer.gov/programs/sbir
The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Small Business Innovation Research (SBIR). To maximize the initiative's capabilities and impact, CPTC is partnering with the biotechnology industry via the NCI's Small Business Innovation Research (SBIR) Program. A contract mechanism that supports early stage research and development by small businesses. Through the SBIR program, CPTC aims to integrate its efforts ...
proteomics.cancer.gov
Programs - Office of Cancer Clinical Proteomics Research - National Cancer Institute
http://proteomics.cancer.gov/programs
The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. FClinical Proteomic Tumor Analysis Consortium. The National Cancer Institute's (NCI) Clinical Proteomic Tumor Analysis Consortium (CPTAC). Is composed of three integrated components:. Proteome Characterization Centers (PCCs). Here for more information about CPTAC. Small Business Innovation Research. US Department of Health and Human Services. 160; National Insti...
proteomics.cancer.gov
June 2013 - Office of Cancer Clinical Proteomics Research - National Cancer Institute
http://proteomics.cancer.gov/newsevents/eprotein/june2013
The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Letter from the Director. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (NCI-CPTAC) has recently begun the proteomic interrogation of genomically-characterized tumors from The Cancer Genome Atlas. Viewing the Targeted Proteomics Horizon with Skyline. Integrating Data with a Focus on Biology. Dialogue on Proteomics in Cancer Research.
proteomics.cancer.gov
What is Proteomics? - Office of Cancer Clinical Proteomics Research - National Cancer Institute
http://proteomics.cancer.gov/whatisproteomics
The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. What is Cancer Proteomics? Refers to the entire complement of proteins, including the modifications made to a particular set of proteins, produced by an organism or a cellular system. This will vary with time and distinct requirements, such as stresses, that a cell or organism undergoes. The term "proteomics". Occur as dictated by the genetic code. In reality, we s...
proteomics.cancer.gov
Investigating RAS Signaling in Cancer - Office of Cancer Clinical Proteomics Research - National Cancer Institute
http://proteomics.cancer.gov/newsevents/newsannouncements/archive/2014/ras
The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Investigating RAS Signaling in Cancer. Posted on December 17, 2014. CPTAC expertise has been charged to develop RAS specific targeted proteomic assays to study the important pathways of human cancer. Assays, reagents and SOPs developed by the awardees will be provided to the public as a community resource to enable studies by cancer researchers in unraveling the oncoge...
proteomics.cancer.gov
Video Tutorial - Office of Cancer Clinical Proteomics Research - National Cancer Institute
http://proteomics.cancer.gov/whatisproteomics/videotutorial
The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. Persons with disabilities having problems accessing the above video file may email cancer.proteomics@mail.nih.gov. US Department of Health and Human Services. 160; National Institutes of Health. 160; National Cancer Institute. 160; USA.gov. NIH…Turning Discovery Into Health.
proteomics.cancer.gov
Open Data Policy - Office of Cancer Clinical Proteomics Research - National Cancer Institute
http://proteomics.cancer.gov/resources/opendatapolicy
The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. The Amsterdam Principles: NCI Leads Proteomic Data Sharing Efforts. The Amsterdam Principles include guidelines for the following:. Responsibility for proteomics data release. The Amsterdam Principles White Paper. 2010 Sydney Meeting Extends The Amsterdam Principles. The answers to this question would form “the quality criteria for shared data” and would be...Share the...
proteomics.cancer.gov
Events - Office of Cancer Clinical Proteomics Research - National Cancer Institute
http://proteomics.cancer.gov/newsevents/events
The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. 14th Annual Innovative Molecular Analysis Technologies PI Meeting. November 21, 2013 8:00 AM - November 22, 2013 3:00 PM. The Innovative Molecular Analysis Technologies (IMAT) program was established to support the development, technical maturation, and dissemination of novel and potentially transformative next-generation technologies through an approach of balanced bu...
proteomics.cancer.gov
News and Events - Office of Cancer Clinical Proteomics Research - National Cancer Institute
http://proteomics.cancer.gov/newsevents
The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. August 29, 2016. University of Victoria Genome British Columbia Proteomics Centre Partners with CPTAC. July 19, 2016. New Memorandum of Understanding in Clinical Proteogenomics Between the United States and Australia. July 11, 2016. Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) Network. June 29, 2016. May 25, 2016. December 28, 2015.
proteomics.cancer.gov
News and Announcements - Office of Cancer Clinical Proteomics Research - National Cancer Institute
http://proteomics.cancer.gov/newsevents/newsannouncements
The National Cancer Institute. The National Institutes of Health. Clinical Proteomics Technologies for Cancer. Sign Up for Email Updates. News and Announcements RSS. August 29, 2016. University of Victoria Genome British Columbia Proteomics Centre Partners with CPTAC. July 19, 2016. White House Office of the Vice President Announces New Memorandum of Understanding in Clinical Proteogenomics Between the United States and Australia. July 11, 2016. June 29, 2016. May 25, 2016. First Large-Scale Proteogenomi...